Kymera Therapeutics Inc (KYMR) support and resistance · rev $99.4M
Kymera Therapeutics Inc (KYMR) is a biotechnology company listed on NASDAQ.
This page maps Kymera Therapeutics Inc (KYMR) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported KYMR revenue for 2026-06-30 was $99.4M. Net income was -$130.4M. KYMR currently screens at market cap $7.39B.
KYMR currently screens at market cap $7.39B. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new KYMR 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the KYMR quote page for the session range and the stock page for the full model.
Not investment advice.